Business:
Therapies for Sanfilippo (SF) Syndrome Type A and Type B.
Drug notes:
AB0-504 RD/Clin0 Stargardt disease; ABO-503 RD/Clin0 x-linked retinoschisis; ABO-505 RD/Clin0 autosomal dominant optic atrophy; AIM Vectors RD undisclosed
About:
Abeona Therapeutics is developing cell and gene therapies for patients with serious diseases. Delivery of gene therapies to the desired tissue without causing an immune response is important for their success. Abeona is using their next-generation adeno-associated viruses (AAVs) to selectively deliver genetic payloads to the central nervous system, lungs, eyes, muscle, liver and other tissues. Abeona’s AAVs are non-replicating and have shown potential to evade immune responses generated by exposure to naturally-occuring AAV vectors. Abeona is applying their AAV technology for several diseases with therapies already in clinical trials. This includes EB-101, in Phase III trials for patients with Epidermolysis Bullosa and other undisclosed targets in preclinical phases.
Sr. Specialist I, Quality Assurance - Quality Oper... Cleveland, OH|today
Specialist II, Quality Assurance - Quality Operati... Cleveland, OH|today
Specialist I, Quality Assurance - Quality Operatio... Cleveland, OH|today
Quality Engineer, Supplier Quality Management Cleveland, OH|1 day ago
Quality Assurance Specialist, Supplier Quality Cleveland, OH|1 day ago
Quality Control Raw Materials - Analyst II Cleveland, OH|9 days ago
Computer System Validation Engineer Cleveland, OH|18 days ago
Quality Control Analyst II Cleveland, OH|39 days ago
Scientific Director Remote|53 days ago
Manufacturing Technician - Logistics (2nd Shift) Cleveland, OH|60 days ago
Environmental Monitoring Associate Cleveland, OH|70 days ago
Senior Validation Engineer Cleveland, OH|79 days ago
Associate, Manufacturing - Operations Cleveland, OH|100+ days ago